APA (7th ed.) Citation

Huber, A., Allam, A. H., Dijkstra, C., Thiem, S., Huynh, J., Poh, A. R., . . . Eissmann, M. F. (2024, August). Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines. Cell Reports.

Chicago Style (17th ed.) Citation

Huber, Anne, et al. "Mutant TP53 Switches Therapeutic Vulnerability During Gastric Cancer Progression Within Interleukin-6 Family Cytokines." Cell Reports Aug. 2024.

MLA (9th ed.) Citation

Huber, Anne, et al. "Mutant TP53 Switches Therapeutic Vulnerability During Gastric Cancer Progression Within Interleukin-6 Family Cytokines." Cell Reports, Aug. 2024.